Drug Approval | November 08, 2025
Alembic receives FDA final approval for Sumatriptan Injection USP
Sumatriptan injection is indicated in adults for the acute treatment of migraine
Sumatriptan injection is indicated in adults for the acute treatment of migraine
PeptiGlow features premium-grade hydrolyzed collagen peptides that support skin elasticity and hydration
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
The complex four-hour surgery was performed by a multidisciplinary team of doctors
Merck and mantro GmbH have established EdiMembre, Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry
Vasograin Plus represents a major advancement in the treatment of migraine
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
Longer-term follow up in the FLAURA2 Phase III trial confirms the favourable benefit-risk profile of this combination
Capstan's lead asset, CPTX2309, is a targeted lipid nanoparticle (tLNP) that delivers an mRNA encoding an anti-CD19 chimeric antigen receptor (CAR) to CD8-expressing cytotoxic T cells in vivo
Extended lab space for product development, customer demos, and training
Subscribe To Our Newsletter & Stay Updated
